The Safe Handling of Antineoplastic Agents

Ng LM . Possible hazards of handling antineoplastic drugs (letter). Pediatrics 1970; 46: 648–9.

Ladik CF Stoehr GP Maurer MA . Precautionary measures in the preparation of antineoplastics (letter). Am J Hosp Pharm 1980; 37: 1184–6.

Crudi CB . A compounding dilemma: I've kept the drug sterile but have I contaminated myself? Natl IV Ther Assoc 1980; 3: 77–8.

Harrison BR . Developing guidelines for working with antineoplastic drugs. Am J Hosp Pharm 1981; 38: 1686–93.

D'Arcy PF . Reactions and interactions in handling anticancer drugs. Drug Intell Clin Pharm 1983; 27: 532–8.

Hirst M Tse S Mills DG . Occupational exposure to cyclophosphamide. Lancet 1984; 2: 186–8.

Falck KG Grohn P Sorsa M . Mutagenicity in urine of nurses handling cytostatic drugs (letter), Lancet 1979; 1: 250–1.

Anderson RW Puckett WH Dana WJ . Risk of handling injectable antineoplastic agents. Am J Hosp Pharm 1982; 39: 1881–7.

Staiano N Galleli JF Adamson RH . Lack of mutagenic activity in urine from hospital pharmacists admixing antitumour drugs (letter). Lancet 1981; 1: 615–6.

Wilson JP Solimando DA . Antineoplastics: A safety hazard? (letter), Am J Hosp Pharm 1981; 38: 624.

Gibson JF Gompertz D Hedworth-Whitty RB . Mutagenicity of urine from nurses handling cytotoxic drugs (letter). Lancet 1984; 1: 100–1.

Norppa H Sorsa M Vainio H . Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs. Scand J Work Environ Health 1980; 6: 299–301.

Waksvik H Klepp O Brogger A . Chromosome analyses of nurses handling cytostatic agents. Cancer Treat Rep 1981; 65: 607–10.

Stiller A Obe G Boll I . No elevation of the frequencies of chromosomal alterations as a consequence of handling cytostatic drugs. Mutation Res 1983; 121: 253–9.

Sontaniemi EA Sutinen S Arranto AJ . Liver damage in nurses handling cytostatic agents. Acta Med Scand 1983; 214: 181–9.

Lasilla O Toivanen A Nordman E . Immune function in nurses handling cytostatic drugs (letter). Lancet 1980; 2: 482.

Jeffrey LP Chairman . National Study Commission on Cytotoxic Exposure. Recommendations for handling cytotoxic agents, 1984.

U.S. Department of Health and Human Services. Public Health Services, National Institutes of Health. Recommendations for the safe handling of parenteral antineoplastic drugs, 1982.

Stolar MH Power LA Viele CS . Recommendations for handling cytotoxic drugs in hospitals. Am J Hosp Pharm 1983; 40: 1163–71.

Harrison BR . Developing guidelines for working with antineoplastic drugs. Am J Hosp Pharm 1981; 38: 1686–93.

Zimmerman PF Larsen RK Barkley EW . Recommendations for the safe handling of injectable antineoplastic drug products. Am J Hosp Pharm 1981; 38: 1693–5.

Davis MR . Guidelines for safe handling of cytotoxic drugs in pharmacy departments and hospital wards. (The Society of Hospital Pharmacists of Australia), Hosp Pharm 1981; 16: 17–20.

Kleinberg ML Quinn MJ . Airborne drug levels in a laminar-flow hood. Am J Hosp Pharm 1981; 35: 1301–3.

National Sanitation Foundation Standard. Class II (laminar-flow) biohazard cabinetry. Standard 49. Ann Arbor, Michigan, May 1983.

Willcox GS Mahoney CD Welch DM . A comparison of laminar air flow cabinetry. Cancer Chemother Update 1983; 1 (2): l–3.

Avis KE Levchuk KE . Special considerations in the use of vertical laminar-flow workbenches. Am J Hosp Pharm 1984; 41: 81–7.

Thomsen K Mikkelsen HI . Protective capacity of gloves used for handling nitrogen mustard. Contact Dermatitis 1975; 1: 268–9.

Connor TH Laidlaw JL Theiss JC . Permeability of latex and polyvinyl chloride gloves to carmustine. Am J Hosp Pharm 1984; 41: 676–9.

Vaccari PL Tonat K DeChristoforo R . Disposal of antineoplastic wastes at the National Institutes of Health. Am J Hosp Pharm 1984; 41: 87–93.

Brink CJ . Employee complaints draw OSHA inspections of hospital procedures for handling cytotoxic drugs (News). Am J Hosp Pharm 1984; 42: 591–2, 595, 600.